SCHEMBL1200181

SCHEMBL1200181

CC(C)CC(C(=O)O)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
RNPEP Q9H4A4 1/20 0.57
SLC7A5 Q01650 1/20 0.57
ALDH1A1 P00352 2/20 0.48
SLC1A3 P43003 1/20 0.48
SLC1A2 P43004 1/20 0.48
CPA1 P15085 2/20 0.44
TP53 P04637 1/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
KMT2A Q03164 1/20 0.44
MME P08473 1/20 0.44
CACNB3 P54284 1/20 0.42
CACNA2D1 P54289 1/20 0.42
CACNA1C Q13936 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroxyamine SCHEMBL20817080 0.94 SLC7A5 (0.59) RNPEPSLC7A5ALDH1A1SLC1A3SLC1A2
SCHEMBL180035 0.85 RNPEP (0.50) RNPEPSLC7A5ALDH1A1SLC1A3SLC1A2
SCHEMBL7624329 0.83 SLC7A5 (0.54) RNPEPSLC7A5ALDH1A1SLC1A3SLC1A2
Hydrochloric Acid SCHEMBL27761977 0.83 RNPEP (0.48) RNPEPSLC7A5ALDH1A1SLC1A3SLC1A2
SCHEMBL16273577 0.83 RNPEP (0.48) RNPEPSLC7A5ALDH1A1SLC1A3SLC1A2
SCHEMBL2474901 0.83 RNPEP (0.48) RNPEPSLC7A5ALDH1A1SLC1A3SLC1A2
SCHEMBL6897228 0.83 SLC7A5 (0.54) RNPEPSLC7A5ALDH1A1SLC1A3SLC1A2
SCHEMBL22272350 0.81 RNPEP (0.46) RNPEPSLC7A5ALDH1A1SLC1A3SLC1A2
SCHEMBL30019003 0.80 TP53 (0.44) RNPEPSLC7A5ALDH1A1SLC1A3SLC1A2
SCHEMBL1458463 0.79 MMP8 (0.53) RNPEPSLC7A5ALDH1A1MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119019655-A Branched PBAT and preparation method thereof 清华大学 2024-11-26 CN claimed
CN-104558291-A Preparation method of catalyst for olefin polymerization CHINA PETROLEUM & CHEMICAL 2015-04-29 CN claimed
CN-104558293-A Catalyst component for olefin polymerization and catalyst CHINA PETROLEUM & CHEMICAL 2015-04-29 CN claimed
CN-104558290-A Components of catalyst for polymerization of olefins and catalyst CHINA PETROLEUM & CHEMICAL 2015-04-29 CN claimed
CN-104558292-A Preparation method of catalyst for olefin polymerization CHINA PETROLEUM & CHEMICAL 2015-04-29 CN claimed
EP-0920461-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS Montell Technology Company bv (NL) 1999-06-09 EP claimed
WO-1998056834-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS MONTELL TECHNOLOGY COMPANY B.V. (NL) 1998-12-17 WO claimed
JP-62059265-A None JP disclosed
CN-119019655-A Branched PBAT and preparation method thereof 清华大学 2024-11-26 CN disclosed
US-20240066132-A1 NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES NOVARTIS AG (CH) 2024-02-29 US disclosed
US-11752211-B2 Fatty acids and their use in conjugation to biomolecules NOVARTIS AG (CH) 2023-09-12 US disclosed
US-20230147962-A1 FIBROBLAST ACTIVATION PROTEIN LIGANDS FOR TARGETED DELIVERY APPLICATIONS PHILOCHEM AG (CH) 2023-05-11 US disclosed
CN-110172019-B Metal salts of malonic acid as nucleating additives for crystalline thermoplastics 印度石油有限公司 2022-03-04 CN disclosed
JP-S6259265-A 1-ETHYL-5-ISOBARBITURIC ACID AND EPITHELIAL CELL CULTURE MEDIUM CONTAINING SAME MEIJI MILK PROD CO LTD 1987-03-14 JP disclosed
EP-0067429-B1 INHIBITORS OF MAMMALIAN COLLAGENASE E.R. Squibb & Sons, Inc. (US) 1986-04-16 EP disclosed
US-4424354-A MERCAPTOALKANOYL DERIVATIVES OF PEPTIDES E. R. SQUIBB & SONS, INC. (US) 1984-01-03 US disclosed
US-4382081-A ANTIARRTHRITIC AGENTS E. R. SQUIBB & SONS, INC. (US) 1983-05-03 US disclosed
EP-0067429-A1 Inhibitors of mammalian collagenase E.R. Squibb & Sons, Inc. (US) 1982-12-22 EP disclosed
US-4263293-A ANTIARTHRITIC AGENTS E. R. SQUIBB & SONS, INC. (US) 1981-04-21 US disclosed
US-4005073-A ANTIBIOTICS HOFFMANN-LA ROCHE INC. (US) 1977-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066132-A1 NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES FABP1, FABP2, FABP3 RNPEP 2476/4885SLC7A5 708/4885ALDH1A1 849/4885
US-11752211-B2 Fatty acids and their use in conjugation to biomolecules FABP1, FABP2, FABP3 RNPEP 2237/4885SLC7A5 789/4885ALDH1A1 907/4885
US-20230147962-A1 FIBROBLAST ACTIVATION PROTEIN LIGANDS FOR TARGETED DELIVERY APPLICATIONS FAP, FIBP, FGFR1 RNPEP 137/4885SLC7A5 1885/4885ALDH1A1 1990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.